RE:RE:DonnatalDonnatal has gone from 38% of revenue in 2014 to 10% after the diversification of the Covis and Amco transactions. Also, Donnatall has recently been approved by the FDA as a generic through an ANDA, which is why concordia is increasing the sales force for Donnatall as it is now listed in the FDA's National Drug Code directory. Good news.... Don't believe the fear mongering.